新闻关注-Shenzhen Bay Laboratory Pingshan Biopharmaceutical R&D and Transformation Center

2021/12/31

Scientific Research Trends | Pingshan Center Developing New Methods for Amination Promotion of Sulfate Salts in Aqueous Phase

Li Zigang, the research group of Chemical biology and Biotechnology of Peking University Shenzhen Graduate School and Pingshan Biomedical R&D and Transformation Center of Shenzhen Bay Laboratory, published a paper entitled "Electronic Sulfonium Promoted Peptide and Protein Enhancement in Aqueous Media" on the magazine Organic Letters.

2021/12/29

Exchange Visit | Director Li Zigang Led a Team to Visit Guangdong Provincial Small Molecular New Drug Innovation Center

On the afternoon of December 27th, Li Zigang, Executive Director of Pingshan Biomedical Research and Transformation Center (hereinafter referred to as "Pingshan Center") at Shenzhen Bay Laboratory, was invited to visit Guangdong Small Molecule New Drug Innovation Center | Shenzhen Small Molecule New Drug Innovation Center Co., Ltd. (hereinafter referred to as "Innovation Center"). Senior executives such as He Xun, General Manager of the Innovation Center, Jin Feng, R&D Director, and Li Zhenwei, Project Director warmly received and held a symposium.

2021/12/20

Pengcheng Laboratory Visits Pingshan Center to Promote Exchange

On December 15, 2021, Chen Jie, the person in charge of the Shennong Platform at Pengcheng Laboratory, and his delegation visited the Pingshan Pharmaceutical Research and Development Transformation Center at Shenzhen Bay Laboratory for exchange and visit.

2021/12/13

Innovation driven development, technology leading the future! The final of the 2021 Beihang Global Science and Technology Innovation Competition Guangdong–Hong Kong–Macao Greater Bay Area will be held in Pingshan

On December 11, 2021, the final of the 5th Beihang Global Science and Technology Innovation Competition Guangdong–Hong Kong–Macao Greater Bay Area was held in Pingshan. The final of the Beihang Global Science and Technology Innovation Competition Guangdong–Hong Kong–Macao Greater Bay Area has been held in Pingshan, Shenzhen for four consecutive times, covering many fields such as artificial intelligence, medical equipment, medical detection, and unmanned driving. As a special witness, Chuangshai has witnessed the high-quality and high-speed development process of "Innovation Pingshan, Future City".

2021/12/13

Professor Fan Yubo, Dean of Beihang Medical and Industrial Cross School, and Chairman Xia Wei of Beihang Investment Co., Ltd. led Beihang Department scientists, investors, and corporate executives to inspect Pingshan Center

On the morning of December 12, Pingshan Biomedical R&D and Transformation Center of Shenzhen Bay Laboratory (hereinafter referred to as "Pingshan Center") welcomed a group of distinguished guests, including Professor Fan Yubo, Chairman of the Chinese Society of Biomedical engineering, President of the Beijing University of Medicine and Engineering, convener of the Economic Committee of the Shenzhen CPPCC, Beihang Investment Co., Ltd. (hereinafter referred to as "Beihang Investment"), and Xia Wei, Chairman of Shenzhen Colorful Group Li Zigang, Executive Director of Pingshan Center and a team of investors and corporate executives, warmly received the inspection team and held a symposium.

2021/12/07

Communication promotes development, and listed company Hanyu Pharmaceutical visits Pingshan Center

On the morning of December 6th, the doctoral team of Hanyu Pharmaceutical, led by Vice President Tang Yangming and Senior Medical Director Li Qingyang, arrived at the Pingshan High tech Zone Industry University Research Base and had an exchange meeting with the Pingshan Biomedical Research and Transformation Center (hereinafter referred to as "Pingshan Center") of Shenzhen Bay Laboratory. The exchange meeting was chaired by Li Zigang, Executive Director of Pingshan Center, The main heads of various departments at Pingshan Center and relevant personnel from the Scientific Research Department of Shenzhen Bay Laboratory participated in this exchange.

2021/12/06

Title level, you are here | Shenzhen Bay Laboratory Nucleic Acid Research Institute is officially recruiting personnel

Shenzhen Bay Laboratory Nucleic Acid Research Institute has officially recruited personnel

2021/12/04

Ye Qingyun, member of the Standing Committee of the Pingshan District Committee, and Liu Yuwen, founding partner of Mint Angel Fund, visited the Pingshan Center for inspection

On December 4th, Ye Qingyun, a member of the Standing Committee of the Pingshan District Committee, and Liu Yuwen, a founding partner of the Peppermint Angel Fund, visited the Pingshan Biopharmaceutical R&D and Transformation Center (hereinafter referred to as the "Pingshan Center") at the Shenzhen Bay Laboratory for inspection. Zhou Liping, Director of the Shenzhen Municipal Health Commission, Huang Ming, Director of the Pingshan Science and Technology Innovation Bureau, and Wu Zhaoling, Director of the Pingshan Health Bureau, accompanied the inspection, Li Zigang, Executive Director of Pingshan Center, and Yin Feng, Minister of Biology, warmly received the visiting leaders.

2021/11/26

Open Day | Integrating Party Building into Scientific Research Activities, Belief Leading Innovative Development

Doing a good job in party building can stimulate the greater potential of scientific researchers, thereby promoting continuous new progress in scientific research innovation. The Second Party Branch of Shenzhen Bay Laboratory carefully learned and understood the spirit of the 22nd Meeting of the Central Comprehensively Deepening Reforms Commission, actively explored a new model of party building activities, let party building enter scientific research activities, transformed the organizational advantages of the party into a driving force for talent scientific and technological innovation, tested the effectiveness of party building with scientific research development, and promoted the integration and mutual promotion of party building and scientific research in the laboratory.

Information disclosure